|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 247.53 USD | +2.21% |
|
+1.52% | +45.61% |
| 17/07 | Canaccord Genuity Initiates Coverage on Jazz Pharmaceuticals With Buy Rating, $290 Price Target | MT |
| 10/07 | Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says | MT |
| Market Cap | 1.55TCr 1.36TCr 1.25TCr 1.16TCr 2.18TCr 1,49700Cr 2.23TCr 15TCr 5.89TCr 73TCr 5.84TCr 5.71TCr 2,52500Cr | P/E 2026 * |
17.7x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 1.72TCr 1.51TCr 1.39TCr 1.28TCr 2.42TCr 1,66100Cr 2.47TCr 17TCr 6.54TCr 81TCr 6.48TCr 6.34TCr 2,80000Cr | EV / Sales 2026 * |
3.82x | EV / Sales 2027 * | 3.22x |
| Free-Float |
96.65% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | +2.21% | ||
| 1 week | +1.52% | ||
| Current month | +2.72% | ||
| 1 month | +10.18% | ||
| 3 months | +21.68% | ||
| 6 months | +46.11% | ||
| Current year | +45.61% |
| 1 week | 233.46 |  | 249.5 |
| 1 month | 222.93 | | 250.49 |
| Current year | 156.95 | | 250.49 |
| 1 year | 105 | | 250.49 |
| 3 years | 95.49 | | 250.49 |
| 5 years | 95.49 | | 250.49 |
| 10 years | 86.88 | | 250.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 11/08/2025 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 01/03/2024 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 01/03/2003 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 18/01/2012 |
Rick Winningham
BRD | Director/Board Member | 66 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Sell | Founder | -6,000 | 0.0096% | ||
| 30/06/26 | Tax | Executive/Senior Manager | -2,527 | 0.0040% | ||
| 30/06/26 | Tax | Chief Executive Officer | -4,835 | 0.0077% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.21% | +1.52% | +119.31% | +91.33% | 1.55TCr | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,05100Cr | |
| +1.23% | -1.53% | +54.58% | +59.08% | 61TCr | |
| +0.04% | +2.58% | +34.47% | +86.33% | 45TCr | |
| +0.78% | -0.71% | +29.28% | +24.10% | 33TCr | |
| +1.41% | +0.58% | +35.44% | +40.67% | 28TCr | |
| -0.27% | -1.87% | +22.34% | +22.51% | 26TCr | |
| -1.76% | +2.37% | -20.43% | -38.00% | 22TCr | |
| -1.42% | +0.80% | +24.27% | +57.50% | 20TCr | |
| -1.48% | +3.43% | +24.08% | +71.67% | 17TCr | |
| Average | +0.16% | +0.64% | +37.61% | +57.65% | 35.91TCr | |
| Weighted average by Cap. | +0.38% | +0.03% | +37.86% | +79.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 451.29Cr 394.38Cr 363.92Cr 335.45Cr 632.25Cr 43TCr 646.29Cr 4.35TCr 1.71TCr 21TCr 1.69TCr 1.66TCr 73TCr | 483.54Cr 422.56Cr 389.93Cr 359.42Cr 677.43Cr 47TCr 692.47Cr 4.66TCr 1.83TCr 23TCr 1.82TCr 1.78TCr 79TCr |
| Net income | 100.23Cr 88Cr 81Cr 75Cr 140.42Cr 9.65TCr 143.54Cr 966.09Cr 379.99Cr 4.73TCr 376.42Cr 368.16Cr 16TCr | 106.71Cr 93Cr 86Cr 79Cr 149.5Cr 10TCr 152.82Cr 1.03TCr 404.54Cr 5.03TCr 400.74Cr 391.95Cr 17TCr |
| Net Debt | 169.82Cr 148.41Cr 136.95Cr 126.23Cr 237.92Cr 16TCr 243.2Cr 1.64TCr 643.82Cr 8.01TCr 637.77Cr 623.78Cr 28TCr | 1.54Cr 1.35Cr 1.24Cr 1.15Cr 2.16Cr 148.58Cr 2.21Cr 15Cr 5.85Cr 73Cr 5.79Cr 5.67Cr 250.5Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $247.53 | +2.21% | 5,03,559 |
| 16/26/16 | $242.18 | +1.20% | 4,30,677 |
| 15/26/15 | $239.32 | +0.53% | 6,10,535 |
| 14/26/14 | $238.05 | +0.46% | 7,47,011 |
| 13/26/13 | $236.97 | -2.81% | 8,38,527 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition